Background The safety and efficacy of tirofiban for patients with acute ischemic stroke (AIS)
remains controversial. We therefore conducted a systematic review and meta-analysis …

Introduction Mechanical thrombectomy is now widely used in acute ischaemic stroke, but its
adjunctive antiplatelet aggregation regimen is controversial. This study aimed to investigate …

Objectives: Tirofiban is widely used in clinical practice for acute ischemic stroke (AIS).
However, whether tirofiban increases the bleeding risk or improves the outcome of AIS …

Introduction Guidelines for antiplatelet therapy administration, during emergent stenting for
extra-cranial internal carotid artery (EC-ICA) occlusion in the setting of acute ischemic stroke …

OBJECTIVE: Our aim is to investigate the efficacy and safety of tirofiban in the treatment of
patients experiencing progressive ischemic stroke (PIS). PATIENTS AND METHODS: A …

Introduction Emergent stenting of the extracranial internal carotid artery (ICA) in stroke
patients requires antiplatelet therapy to prevent in-stent thrombosis with a higher risk of …

Background: Neurointerventional procedures in acute ischemic stroke often require
immediate antiplatelet therapy in the cases of acute stenting and occasionally re-occluding …

In this meta-analysis, we explored whether tirofiban could safely improve outcomes when
combined with endovascular therapy in acute ischemic stroke with large vessel occlusion …

Background Tirofiban is an antiplatelet treatment approved for acute coronary syndrome, but
it has not been rigorously evaluated for efficacy and safety in patients with acute ischemic …

Introduction Carotid artery stenting (CAS) has increasingly emerged as an alternative
strategy to carotid endarterectomy in the treatment of patients with symptomatic carotid …